Lambert-Eaton myasthenic syndrome has a more progressive course in patients with lung cancer

Muscle and Nerve

Volumn 32, Issue 2, 2005, Pages 226-229

  Wirtz, Paul W ^a   Wintzen, Axel R ^a   Verschuuren, Jan J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Lambert Eaton myasthenic syndrome; Muscle weakness; Small cell lung cancer; Voltage gated calcium channel

Indexed keywords

ADULT; AGED; AUTONOMIC NEUROPATHY; BULBAR PARALYSIS; CEREBELLAR ATAXIA; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIPLOPIA; DISEASE COURSE; DYSPHAGIA; EATON LAMBERT SYNDROME; FEMALE; HUMAN; IMPOTENCE; LUNG CANCER; LUNG SMALL CELL CANCER; MALE; MEDICAL RECORD; MICTURITION DISORDER; MUSCLE WEAKNESS; PRIORITY JOURNAL; PTOSIS; REVIEW; SLURRED SPEECH; SYMPTOMATOLOGY; XEROSTOMIA;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AUTONOMIC NERVOUS SYSTEM; CARCINOMA; CENTRAL NERVOUS SYSTEM; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; NETHERLANDS;

EID: 23044503286     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20332     Document Type: Review

References (9)

1. Burns TM, Russell JA, LaChance DH, Jones HR. Oculobulbar involvement is typical with Lambert-Eaton myasthenic syndrome. Ann Neurol 2003;53:270-273.
2. Lambert EH, Rooke ED. Myasthenie state and lung cancer. In: Brain WR, Morris FH, editors. The remote effects of cancer on the nervous system. New York: Grune & Stratton; 1965, p 67-80.
3. Motomura M, Johnston I, Lang B, Vincent A, Newsom-Davis J. An improved diagnostic assay for the Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 1995;58:85-87.
4. Nakao YK, Motomura M, Fukudome T, Fukuda T, Shiraishi H, Yoshimura T, et al. Seronegative Lambert-Eaton myasthenic syndrome: study of 110 Japanese patients. Neurology 2002;59:1773-1775.
5. O'Neill JH, Murray NMF, Newsom-Davis J. The Lambert Eaton myasthenic syndrome. A review of 50 cases. Brain 1988;111:577-596.
6. Wirtz PW, van Dijk JG, van Doom PA, van Engelen BGM, van der Kooi AJ, Kuks JB, et al. The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands. Neurology 2004;63:397-398.
7. Wirtz PW, Smallegange TM, Wintzen AR, Verschnuren JJ. Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases. Clin Neurol Neurosurg 2002;104:359-363.
8. Wirtz PW, Sotodeh M, Nijnuis M, Van Doom PA, Van Engelen BG, Hintzen RQ, et al. Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 2002;73:766-768.
9. Wirtz PW, Willcox N, van der Slik AR, Lang B, Maddison P, Koeleman BP, et al. HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome. J Neuroimmunol 2005;159:230-237.